Real-world data on PD-1 inhibitor therapy in metastatic melanoma.

Arheden, Anna; Skalenius, Joanna; Bjursten, Sara; Stierner, Ulrika; Ny, Lars; Levin, Max; Jespersen, Henrik

Arheden, Anna; Skalenius, Joanna; Bjursten, Sara; Stierner, Ulrika; Ny, Lars; Levin, Max; Jespersen, Henrik.

Affiliation

Arheden A; a Department of Oncology , Sahlgrenska University Hospital , Gothenburg , Sweden.
Skalenius J; b Department of Obstetrics and Gynecology , Sahlgrenska University Hospital , Gothenburg , Sweden.
Bjursten S; a Department of Oncology , Sahlgrenska University Hospital , Gothenburg , Sweden.
Stierner U; c Department of Oncology , Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg , Gothenburg , Sweden.
Ny L; a Department of Oncology , Sahlgrenska University Hospital , Gothenburg , Sweden.
Levin M; c Department of Oncology , Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg , Gothenburg , Sweden.
Jespersen H; a Department of Oncology , Sahlgrenska University Hospital , Gothenburg , Sweden.

Acta Oncol ; 58(7): 962-966, 2019 Jul.

Article in En | MEDLINE | ID: mdl-31151362

Subject(s)

Antineoplastic Agents, Immunological/administration & dosage; Melanoma/drug therapy; Programmed Cell Death 1 Receptor/antagonists & inhibitors; Rheumatic Diseases/epidemiology; Skin Neoplasms/drug therapy; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological/adverse effects; Clinical Trials, Phase III as Topic; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Melanoma/mortality; Melanoma/secondary; Middle Aged; Mutation; Programmed Cell Death 1 Receptor/immunology; Proto-Oncogene Proteins B-raf/genetics; Retrospective Studies; Rheumatic Diseases/chemically induced; Rheumatic Diseases/immunology; Skin Neoplasms/mortality; Skin Neoplasms/pathology; Sweden/epidemiology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Skin Neoplasms / Rheumatic Diseases / Programmed Cell Death 1 Receptor / Antineoplastic Agents, Immunological / Melanoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2019 Type: Article Affiliation country: Sweden

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google